Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Mol Cancer Ther. 2011 Jan;10(1):159–168. doi: 10.1158/1535-7163.MCT-10-0631

Table 1.

Surviving fraction after treatments

Cell Line Plating efficiency (PE) RT Surviving fraction (SF) U0126 Surviving fraction (SF) U0126 + RT Surviving fraction (SF)
RD 0.8 0.67 0.17 0.08
RD-M1 0.67 0.42 0.3 0.14
TE671 0.84 0.83 0.24 0.11